May 2015

20 May

New Drug Discovery Company Announces Additional Funding to Tackle Chronic Respiratory Disease

In All, Portfolio

Brighton, Sussex, May 20th 2015 – Enterprise Therapeutics Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing. The funds are comprised of £2m by new investor, Imperial Innovations and…

07 May

Harpoon Medical Enrolls Initial Three Patients In Early Feasibility Study Of Its Repair System For Off-Pump, Minimally Invasive Treatment Of Mitral Valve Regurgitation

In All, Portfolio

Baltimore, MD, May 7, 2015 – Harpoon Medical, a medical device company focused on minimally invasive mitral valve repair, announced today that it has enrolled the initial three patients in an Early Feasibility Study of its repair system for the minimally invasive, beating-heart treatment of MR….